Biotech & Longevity: 15 Jun – 21 Jun
No boards ran in this window, so there is no arc to read.
—
pressure at the week’s end, 0–100
—
move across the week
7
editions published
560
sources read behind them
No written analysis for this week
Everything on this page is measured from the week’s own boards and editions. The written read is added when the engine runs its report pass; a week without one still has its record.
The week’s editions · 7
A one-time gene edit cut a rare disease's attacks by 87% — the first phase 3 proof that CRISPR works inside the body
An mRNA flu shot goes to the FDA — and the math of giving anything to millions
The week the FDA changed its mind about what counts as proof
The week a 200,000-woman cancer screening trial finally explained why it failed
A depression drug just lost to a sugar pill three times in a row
Scientists edited the red out of lettuce — and other compounds quietly took its place
The week a therapy to make old cells young again was put into a person for the first time
The same week, another beat